secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2025-07-25T23:59:59+00:00
Accession:  0000950170-25-098578
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Q2 revenue $18.6B (+6.4%), EPS $6.83 (+23.5%); raises 2025 guidance
-----------------------------------------------------------------------

- Revenue $18.605B (+6.4% YoY); net income $1.653B (+13.1% YoY).
- Diluted EPS $6.83 (+23.5%); adjusted diluted EPS $6.84 (+24.4%).
- Adjusted EBITDA $3.849B (+8.4%); same facility admissions +1.8%.
- Quarterly cash dividend declared at $0.72/share, payable Sep 30, record Sep 16.
- Company announces it is raising full-year 2025 guidance (specific new figures not provided in filing excerpt).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000095017025098578/0000950170-25-098578-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000095017025098578/hca-20250725.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-098578

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer